Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NxStage Medical Inc (NASDAQ:NXTM)

17.29
Delayed Data
As of Feb 08
 -0.71 / -3.94%
Today’s Change
13.47
Today|||52-Week Range
22.60
-21.09%
Year-to-Date
No recent news for NxStage Medical Inc.

Today’s Trading

Previous close18.00
Today’s open17.92
Day’s range16.96 - 18.06
Volume735,878
Average volume (3 months)526,411
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)+37.61%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.45%
P/E ratioNM
Price/Sales3.67
Price/Book5.92

Competitors

 Today’s
change
Today’s
% change
DBVTDBV Technologies SA-1.06-4.37%
EXELExelixis Inc-0.29-6.39%
FGENFibroGen Inc-1.88-11.30%
ARIAARIAD Pharmaceutical...-0.47-9.27%
Data as of 4:00pm ET, 02/08/2016

Financials

Next reporting dateFebruary 10, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$301.5M
Annual profit (last year)-$23.9M
Net profit margin-7.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Jeffrey H. Burbank
President
Joseph E. Turk
Corporate headquarters
Lawrence, Massachusetts

Forecasts

Partner Offers